Corporate governance > Board of Directors
According to its Articles of Incorporation, Revenio Group Corporation’s Board of Directors is to be composed of no fewer than three (3) and no more than eight (8) members.
The requirements set by the Company’s operation and its development phase will be considered with regard to the composition of the Board of Directors. A candidate to the Board of Directors must have the necessary qualifications for the position and the time to fulfill their duties. The number of members on the Board of Directors and its composition must enable efficient performance when the Board’s tasks are being managed.
The general meeting of shareholders elects the members of the Board. The Board elects its Chair from among its members. All members of the Board of Directors are non-executive directors. According to the Articles of Incorporation, the term of a member of the Board is one year beginning at the end of the general meeting of shareholders at which the member was elected and ending at the close of the next ordinary general meeting of shareholders.
In the preparation for the selection of Board members and the proposal to the General Meeting, attention is paid to the members' diverse and complementary backgrounds, experience, expertise, age, gender, and perspectives, as well as to Revenio's business. The aim is to ensure that the diversity of the Board supports Revenio's business, markets, and future in the best possible way. Both genders must be represented on the board.
The representation of both genders is realized in Revenio's Board, and both genders have been represented for a long time. At the 2026 General Meeting, five members were elected to the board, representing four different nationalities. Of the Board members, two are women and three are men. The age of the Board members ranges from 41 to 66 years. The Board members have international work experience in globally operating companies and have held or currently hold executive, board, and trust positions in both listed and unlisted companies.
All Board members are independent of the Company and its major shareholders.
The Board reviews the neutrality of its members on a regular basis. Board members are obligated to provide the Board of Directors with the information required for the assessment of neutrality.
The task of Revenio Group Corporation’s Board of Directors is to further the interests of the Company and all of its shareholders. Members of the Board do not represent the entities or persons who nominated them for election. Members of the Board are disqualified from participating in the management of matters or transactions taking place between themselves and the Company. Voting is based on the simple majority vote principle. In the case of an even vote, the proposal supported by the Chair will prevail.
The Chair is responsible for convening and presiding over the Board meetings. The Board has not assigned to its members any particular areas of business to be monitored. The Board annually reviews its operation and procedures, and performs self-assessments at necessary intervals.
The Board is responsible for the Company’s administration and the appropriate organization of the Company’s business operations. It makes decisions on principles governing corporate strategy, organization, accounting, and finances.
The Board appoints the Company’s President & CEO and, based on the CEO’s proposals, the members of the Group Management Team. It also ratifies the Company’s organization and structure. The Board has established an audit committee responsible for the tasks of an audit committee according to the Governance Code.
The Board has prepared a written charter of its operation, which is updated as necessary.
The Board holds regular meetings approximately once a month and more often as required. The Company ensures that all members of the Board of Directors have sufficient information on the Company’s operation, operating environment, and financial position, and that any new member of the Board receives induction into the Company’s operation.
As stipulated by its charter, the Board’s principal tasks are to:
decide on Group strategy and ratify the strategies of the various business areas;
approve the Group’s annual plan (budget);
approve the Group’s financing and investment policies;
ratify the Group’s risk management principles, and discuss the Group’s most important risks and factors of uncertainty;
confirm and ratify the Group’s insurance policy;
discuss and approve the consolidated financial statements, interim financial reports, stock exchange releases pertaining to these, and the review of operations;
significant contracts;
decide on specific investments, acquisitions, divestments, corporate reorganization and commitments that have strategic or financial importance;
decide on rules concerning management authorizations;
decide on the Group’s high-level structure and organization;
appoint and dismiss the President & CEO, approve the CEO’s service contract, and decide on the CEO’s salary, benefits, and other financial remuneration;
approve the appointments of the members of the Group Management Team, the Managing Directors of subsidiaries, their salaries and financial benefits;
decide on the remuneration schemes of the Revenio Group, including the granting of share-based bonuses within limits set by the AGM.
The Board of Directors decided on May 10, 2019 to establish an Audit Committee.
The Board elected the following members from among its members for the Committee: Heli Lindfors, Arne Boye Nielsen and Bill Östman. The Board of Directors elected Heli Lindfors as Chair of the Audit Committee.
The members of the Audit Committee have sufficient expertise and experience with respect to the committee’s area of responsibility and the mandatory tasks relating to auditing.
Composition and term of office of the audit committee
The Board of Directors shall elect the members and the chairperson of the Audit Committee from among its members at its first meeting following the Annual General Meeting. The term of office of the members is one year and ends at the close of the next Annual General Meeting
The Committee shall comprise a minimum of three members. The majority of the members of the Audit Committee shall be independent of the Company. At least one member shall be independent of the Company’s significant shareholders. The Managing Director or any other member of the Company’s executive management team shall not be eligible for membership of the Audit Committee.
The Audit Committee shall, as a whole — taking into account the complementary expertise, competence and industry knowledge of its respective members — possess sufficient expertise and experience in matters falling within the Committee’s remit and in the operating environment in which the Company operates. Pursuant to applicable legislation, at least one member of the Audit Committee shall possess expertise in accounting or auditing.
Pursuant to the Finnish Companies Act, a person who participates in the day-to-day management of the Company or any company belonging to the same group of companies shall not be appointed as a member of the Audit Committee.
Duties of the audit committee
The audit committee shall assist the board of directors in the preparation of matters falling within the board's competence. The committee is not an autonomous decision-making body, notwithstanding its several monitoring and supervisory responsibilities. The committee shall report to the board of directors on the matters it has addressed and the measures it has undertaken. The committee shall submit proposals to the board of directors for decision-making where appropriate.
The responsibilities of the audit committee include:
Financial reporting
Internal Control, Internal Audit and Risk Management
Reporting and Governance
Compliance
Other Duties
Working methods of the Audit Committee
The Audit Committee shall convene no fewer than five times per year. The Chairperson shall convene the meetings of the Audit Committee. The secretary of the Committee meeting may also be the Group Chief Financial Officer or an external person appointed for the purpose who possesses the requisite qualifications. A meeting of the Committee shall constitute a quorum when the Chairperson and at least one member are present.
The Managing Director and the Chief Financial Officer shall attend the meetings of the Committee. Other people responsible of the Company shall attend the meetings as necessary upon invitation by the Committee.
The Audit Committee shall prepare an annual meeting schedule, which shall include the principal matters to be addressed.
Minutes of the Audit Committee meetings shall be prepared without undue delay and shall be signed by at least the Chairperson and the secretary. The minutes of the Committee meetings shall be distributed to all members of the Board of Directors. The Chairperson of the Audit Committee shall report on the Committee’s activities to the Board of Directors at the next meeting of the Board of Directors.
The Audit Committee shall meet with the auditors, internal auditors and other internal experts of the Company as necessary. The Audit Committee shall also meet with the sustainability reporting assurance provider as necessary. The Audit Committee may engage external advisors as it deems appropriate.
Evaluation of the committees work
The Audit Committee shall conduct a self-assessment of its work once per year. The Chairperson of the Committee shall report the results to the Board of Directors.
The Board of Directors decided on October 21, 2020 to establish a Nomination and Remuneration Committee.
The Board has elected the following members from among its members for the Committee: Bill Östman, Riad Sherif and Arne Boye Nielsen. The Board of Directors elected Bill Östman as Chair of the Nomination and Remuneration Committee.
The members of Nomination and Remuneration Committee have sufficient expertise and experience with respect to the committee's area of responsibility.
The Board of Directors appoints the members and the chair of the Nomination and Remuneration Committee from amongst the Board.
The members of the Nomination and Remuneration Committee shall have the expertise and experience required for the duties of the Committee. The majority of the members of the Committee shall be independent of the company, and the Committee shall act independently when carrying out duties related to remuneration. The CEO or other persons in the management of the company may not be appointed to the Committee.
The Committee will nominate a secretary who will sign the minutes of the meetings together with the chair.
The Nomination and Remuneration Committee assists the Board of Directors in the preparatory work on the election of directors, on remuneration and nomination of the CEO and other management, and on remuneration schemes for other personnel.
The duties of the Nomination and Remuneration Committee include:
the preparation of the appointment of the CEO and other senior executive management as well as successor planning
the preparation of the salary and other financial benefits of the CEO and other senior executive management
the preparation of matters concerning the company’s remuneration schemes
the assessment of the remuneration of the CEO and other senior executive management as well as seeing to the appropriateness of the remuneration schemes
the preparation of the remuneration policy and report
the presentation of the remuneration policy and report in the general meeting and responding to questions related thereto
other tasks and reports relating to remuneration and the appointment of executives, as assigned to the Committee by the Board of Directors
The Remuneration and Nomination Committee convenes at least two times per year in accordance with the agreed schedule or at the invitation of the chair. The invitation and the agenda will be sent to the participants of the meeting as well as to the attention of other members of the Board of Directors.
The Committee is competent when the chair of the Committee and at least one member of the Committee is present.
The CEO can also be invited to attend the meeting if the Committee deems it necessary.
The Committee has the authority to have analyses and studies made on all matters within its competence.
Minutes will be drawn up of the meetings of the Committee, and they will be signed at least by the Committee's chair and secretary. The minutes will be made available to the members of the Board of Directors. The matters addressed at the Committee's meetings will be reported to and discussed by the Board of Directors of the company. The Committee will also otherwise report on its operations on a regular basis.

b. 1968, Danish citizen
M.Sc. in Business Administration
Chair of the Board
Member of the Audit Committee
Member of the Nomination and Remuneration Committee
Board member since June 8, 2020
Independent from the company and its major shareholders
Demant A/S: President, Diagnostics and Communications, member of the Executive Board
Embla Medical hf: Board member
Cookie information A/S: Board member
Natus Sensory: Board member

b. 1958, Finnish citizen
M.Sc. (Technical Physics)
Vice Chair of the Board
Chair of the Nomination and Remuneration Committee
Member of the Audit Committee
Board member since June 8, 2020
Independent from the company and its major shareholders
Thermo Fisher Scientific: Vice President & General Manager

b. 1968, French citizen
MBA, Master's Degree (Medical Management), Medical Doctor
CEO, Oculis
Member of the Nomination and Remuneration Committee
Board member since April 8, 2022
Independent from the company and its major shareholders
Novartis: Entrepreneur in Residence at Novartis Venture Fund; Chief Executive Officer, Canada; President, Latin America Region; Head of Infectious Disease Transplant and Immunology, Latin America Region; Head of Global Sales, Transplant and Immunology
Alcon: President, EMEA
Sanofi: Algeria Country Manager; Regional Marketing Manager, Africa, Middle East, French Overseas and Dom Tom; Brand Management and Area Marketing Manager, Paris
NexMed Plus (Switzerland): Chair of the Board
-optimized.jpg)
b. 1959, Israeli citizen
MD, MHA
Board member since April 10, 2025
Head of Retina, Tel Aviv Medical Center 2023-
VP Ambulatory Services, Tel Aviv Medical Center 2023-
Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center 2000-2023
Vice Dean of Medical School, Tel Aviv University 2006-2022
Member of the National Council of Surgery
Member of the Israeli Academy of Medicine
Member ofthe Academia Ophthalmological Internationalis
President, Israeli Ophthalmological Society
Board member, NotalVision
Board member, Pulsenmore
Board member, ESASO (European School for Advanced Studies in Ophthalmology)
Sidney Fox Chair of Ophthalmology at the Gray Faculty of Medicine at Tel Aviv University
Editor in Chief of the Journal Case Reports in Ophthalmology
Associate editor of Investigative Ophthalmology & Visual Science Journal, European Journal of
Ophthalmology, and of Ophthalmologica

b.1984, Finnish citizen
M.Sc. (Econ)
Chair of the Audit Committee
Board member since April 10, 2025
CFO, Vaisala Oyj 2023-
Senior Vice President Finance, Kalmar, Cargotec 2022–2023
Vice President Finance, Kalmar, Cargotec 2017–2021
Several finance positions, Cargotec 2010–2016
Auditor, Ernst & Young, 2007–2010